Pancreatic Cancer Research

ResearcherJiaxing UniversityActive in the last 2 years

Daiwen Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8351-7421; OpenAlex author ID A5100396686. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. miR-630 as a therapeutic target in pancreatic cancer stem cells: modulation of the PRKCI-Hedgehog signaling axis. Last author DOI 10.1186/s13062-024-00539-1↗
  2. Correction: A Ketogenic Diet in Combination with Gemcitabine Increases Survival in Pancreatic Cancer KPC Mice. Co-author DOI 10.1158/2767-9764.crc-22-0510↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Zou · 1 shared paper, 2024 · strength 0.26
  2. Natalia E. Cortez · 1 shared paper, 2022 · strength 0.13
  3. Cecilia Rodríguez Lanzi · 1 shared paper, 2022 · strength 0.13
  4. Jihao Xu · 1 shared paper, 2022 · strength 0.13
  5. Gerardo Guillermo Mackenzie · 1 shared paper, 2022 · strength 0.13
  6. Chang‐Il Hwang · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.